Evidence map›Paper›PMID 41903444›Full record

ArticleMolecular pharmacology2026

CXCR1 and CXCR2 display receptor bias for shared chemokine agonists.

Chanpreet Jassal, Joseph Strawn, Emily Walsh, Krishna Rajarathnam, Sudarshan Rajagopal

Abstract read
In one paragraph

Article in Molecular pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Chanpreet JassalDepartment of Medicine, Duke University School of Medicine, Durham, North Carolina.
Joseph StrawnDepartment of Medicine, Duke University School of Medicine, Durham, North Carolina.
Emily WalshTrinity College of Arts and Sciences, Duke University, Durham, North Carolina.
Krishna RajarathnamDepartment of Biochemistry and Molecular Biology, Department of Microbiology and Immunology, Institute for Human Infections and Immunity, Sealy Center for Structural Biology and Molecular Biophysics, University of Texas Medical Branch, Galveston, Texas. Electronic address: krrajara@utmb.edu.
Sudarshan RajagopalDepartment of Medicine, Duke University School of Medicine, Durham, North Carolina. Electronic address: sudarshan.rajagopal@duke.edu.

Funding

Biasing CXCR3 Signaling to Modulate the Inflammatory ResponseR01GM122798 · NIGMS · DUKE UNIVERSITY · PI RAJAGOPAL, SUDARSHAN · 2017 to 2025
$3.2M
A Novel high resolution MS platform for high-throughput screening of G protein-coupled receptorsR01GM149650 · NIGMS · BATTELLE PACIFIC NORTHWEST LABORATORIES · PI Jon Jacobs, Sudarshan Rajagopal · 2023 to 2026
$1.6M
NIGMS NIH HHS R01 GM122798NIGMS NIH HHS R01 GM149650
6 · The paper itself

Abstract

G protein-coupled receptors (GPCRs) mediate diverse signaling outputs through their proximal transducers: G proteins, GPCR kinases, and β-arrestins. Although ligand bias at chemokine receptors (CKRs), where ligands for the same receptor display distinct signaling patterns, is well recognized, receptor bias, where the same agonist at different receptors yields distinct transducer engagement, remains poorly understood. We compared endogenous chemokine ligands (CXCL1, CXCL5, CXCL7, CXCL8) at the highly homologous CXCR1 and CXCR2 using biosensor assays to measure Gαi activation, β-arrestin1/2 recruitment, GPCR kinase 2/3/5/6 translocation, and receptor internalization. Our data reveal qualitatively different signaling patterns, most notably where CXCL1 acts as a G protein-biased partial agonist at CXCR1 but as a balanced full agonist at CXCR2. These signaling differences correlate with receptor internalization but not subcellular ERK activation patterns measured using compartment-specific biosensors. Collectively, our findings demonstrate receptor bias in CKR signaling, transducer activation, and compartmentalized kinase activation in translating chemokine identity into discrete functional outcomes. SIGNIFICANCE STATEMENT: Ligand bias, where different ligands for the same receptor display different signaling patterns, is now well appreciated. However, there are only a few examples of receptor bias, where the same agonist generates distinct signaling profiles at different receptors. This study used biosensors and compartmental ERK biosensors to show that shared ligands of CXCR1 and CXCR2 differentially engage G proteins, β-arrestins, and G protein-coupled receptor kinases, revealing receptor bias in CXCL1-mediated signaling that extends beyond prior characterizations.

Indexed as

ChemokinesReceptors, Interleukin-8AReceptors, Interleukin-8BAnimalsbeta-Arrestin 2beta-ArrestinsBiosensing TechniquesChemokine CXCL1HEK293 CellsHumansLigandsSignal Transductionbeta-Arrestin 2beta-ArrestinsChemokine CXCL1ChemokinesCXCR2 protein, humanLigandsReceptors, Interleukin-8AReceptors, Interleukin-8BBiased agonismChemokineChemokine receptorG protein–coupled receptorReceptor bias

Identifiers

PMID41903444
PMCPMC13168994

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.